LAWRENCE DAVID 4
4 · ACORDA THERAPEUTICS INC · Filed Feb 25, 2019
Insider Transaction Report
Form 4
LAWRENCE DAVID
Chief Financial Officer
Transactions
- Sale
Common Stock
2019-02-22$13.18/sh−761$10,028→ 5,092 total
Footnotes (2)
- [F1]Reflects the number of shares of the issuer's Common Stock that were sold to cover tax liability in connection with settlement of restricted stock units that vested as reported on a prior Form 4.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $12.9666 to $13.18000 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.